Position in AZN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$760,186
-$29,285 QoQ
Shares Held
4,009
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#735
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Five Oceans Advisors holds $7,614,351 across 12 Drug Manufacturers - General names. AZN ranks #5 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,208 | $1,448,911 | |
| 2 | NVS |
Novartis AG
|
7,908 | $1,239,341 | |
| 3 | JNJ |
Johnson & Johnson
|
4,196 | $1,065,658 | |
| 4 | ABBV |
AbbVie Inc.
|
3,640 | $915,969 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
4,009 | $760,186 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,157 | $405,674 | |
| 7 | NVO |
Novo Nordisk A S
|
7,396 | $354,564 | |
| 8 | AMGN |
Amgen Inc
|
931 | $337,133 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $760,186 | 4,009 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $789,471 | 4,003 | Shares | Sole | 2026-04-07 | |
| No filing history on record for this holder in this stock. | ||||||